Further investigation of AHR regulation of ACE2 and the downstream effects of the ACE2 cleavage product, Ang-(1–7), on Mas and AT2R may identify novel therapeutic targets in hypertension and fibrosis. This evidence concerns the gene AHR and hypertensive disorder.